Antitumor therapy comprising distamycin derivatives

Details for Australian Patent Application No. 2002221622 (hide)

Owner Pharmacia and Upjohn Company LLC Pharmacia Italia S.p.A.

Inventors Geroni, Maria Cristina Rosa; Vreeland, Franzanne; Fowst, Camilla

Agent Griffith Hack

Pub. Number AU-B-2002221622

PCT Pub. Number WO02/28389

Priority 09676770 02.10.00 US

Filing date 21 September 2001

Wipo publication date 15 April 2002

Acceptance publication date 17 May 2007

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 May 2007 Application Accepted

  Published as AU-B-2002221622

13 September 2007 Standard Patent Sealed

6 March 2008 Assignment Registered

  Pharmacia and Upjohn Company LLC; PHARMACIA ITALIA S.p.A. The patent has been assigned to Nerviano Medical Sciences S.r.l.

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002221623

2002221621